Industry News
Signatera MRD identifies breast cancer patients who can forgo surgery
Prospective study published in Clinical Cancer Research shows that women >70 who tested Signatera MRD-negative could avoid surgery and remain progression-free
News & Articles
25
Selected Filters:
Industry News
Natera and Personalis partner for personalized monitoring in oncology
The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring
Industry News